Evolution of resuscitation fluid for hemorrhagic shock——low titer group O whole blood is becoming preferred emergent universal bridging resuscitation fluid
Journal Title: Chinese Journal of Blood Transfusion - Year 2024, Vol 37, Issue 8
Abstract
Timely and effective blood resuscitation is very important for patients with severe blood loss. The resuscitation fluids for hemorrhagic shock have evolved from whole blood to crystalloid/colloid solutions, crystalloid combined with red blood cells, to balanced blood components. In the past 20 years, it is a growing trend that low titer antibody group O whole blood (LTOWB) is used as the preferred universal bridging resuscitation fluid for emergent blood resuscitation. Herein we provide a review of the history and current status of whole blood for patients with severe bleeding and make a suggestion to launch a national implementation research program of LTOWB in China.
Authors and Affiliations
Hongjie WANG, Yongjian GUO
Removal of serological interference in the treatment of multiple myeloma with CD38 monoclonal antibody using polybrene method
Objective To investigate the clinical feasibility of polybrene method to remove serological interference in patients receiving anti-CD38 monoclonal antibody for the treatment of multiple myeloma, and its detection perfor...
Dentification and blood transfusion therapy of anti-C, e alloantibodies with anti-e, Jkb mimicking alloantibodies
Objective To investigate the differential diagnosis of 1 anti-C, e alloantibodies combined with anti-e, Jkb mimicking alloantibodies by absorption-elution test and titer integral method. Methods ABO, Rh and Kidd blood gr...
Frequency of double population of Rh blood group C and E antigen after transfusion of allogeneic red blood cells and its influence on blood transfusion efficacy
Objective To prove the necessity of precise red blood cell transfusion by studying the frequency of double population of Rh blood group C and E antigen after allogeneic red blood cell transfusion in our hospital and its...
Matching strategy for patients with platelet transfusion refractoriness caused by compound antibodies against HLA and CD36
Objective To search compatible and suitable platelets for platelet transfusion refractoriness (PTR) patient caused by compound antibodies against HLA and CD36. Methods ELISA method was used to detect the antibody against...
In vitro quality evaluation of leucocyte-reduced pooled platelet concentrates prepared from whole blood stored at 4℃
Objective To investigate the feasibility of leucocyte-reduced pooled platelet concentrates from whole blood stored at 4℃, and provide theoretical basis for the components preparation. Methods The collected 400 mL ACD-B a...